Loading clinical trials...
Loading clinical trials...
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Conditions
Interventions
CP-690,550
CP-690,550
Locations
469
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Rheumatology Associates of North Alabama, PC
Huntsville, Alabama, United States
Arthrocare, Arthritis Care & Research, PC
Gilbert, Arizona, United States
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, Arizona, United States
Radiant Research, Inc.
Scottsdale, Arizona, United States
Catalina Pointe Clinical Research
Tucson, Arizona, United States
Start Date
February 5, 2007
Primary Completion Date
November 30, 2016
Completion Date
October 26, 2017
Last Updated
October 30, 2018
NCT07017686
NCT05038553
NCT05790356
NCT03429426
NCT06028438
NCT06800157
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions